Imatinib in patients with metastatic gastrointestinal stromal tumours relapsing after hepatic transplantation.
Bompas
Emmanuelle
E
Boillot
Olivier
O
Bringuier
Pierre-Paul
PP
Dumortier
Jérôme
J
Blay
Jean-Yves
JY
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D003240:Connective Tissue Diseases / Q000188:drug therapy*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D000068877:Imatinib Mesylate; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016031:Liver Transplantation; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001549:Benzamides; D007166:Immunosuppressive Agents; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate